| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/08/2001 | US6229055 Synthesis of fluorinated xanthene derivatives |
| 05/08/2001 | US6229005 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent |
| 05/08/2001 | US6228991 Amino acid sequence; diagnosis, treatment or prevention of reproductive, developmental, neoplastic, and immunological/ autoimmune disorders; anticarcinogenic agents; antitumor/antiarthrtic/antidiabetic agents; endometriosis |
| 05/08/2001 | US6228984 Polypeptides their production and use |
| 05/08/2001 | US6228838 Bactericide or antibiotic screening; genetic engineering |
| 05/08/2001 | US6228837 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/08/2001 | US6228835 Decorin binding protein compositions |
| 05/08/2001 | US6228644 Nucleotide and amino acid sequences; for transgenic plants with disease resistance, enhanced growth, and/or insect control |
| 05/08/2001 | US6228638 Nucleotide sequence of rna which binds to and antagonizes ability of csra to down-regulate production of certain metabolic products; for altering expression of desired compounds in bulk bacterial cultures |
| 05/08/2001 | US6228621 Plasmids encoding immunogenic proteins and intracellular targeting sequences |
| 05/08/2001 | US6228619 Glucosaminidase |
| 05/08/2001 | US6228618 Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
| 05/08/2001 | US6228617 Nucleotide sequence coding a trigger chaperone protein; for use in screening bactericides |
| 05/08/2001 | US6228616 Human anion channel |
| 05/08/2001 | US6228610 Human metabotropic glutamate receptor subtypes (hmR4, hmR6, hmR7) and related DNA compounds |
| 05/08/2001 | US6228608 Recombinant FIV glycoprotein 160 and P24 gag protein |
| 05/08/2001 | US6228600 Immunoassays for the alpha platelet-derived growth factor receptor |
| 05/08/2001 | US6228599 Antibody specific for homogalacturonan |
| 05/08/2001 | US6228597 Counting thyrotropin in a sample; incubate transformed cells with membranes containing thyrotropin, measure adustment in adenylate cyclase activity |
| 05/08/2001 | US6228594 Method for determining the presence or absence of a hereditary hemochromatosis gene mutation |
| 05/08/2001 | US6228584 Nucleotide sequences for use in the detection of streptococcus |
| 05/08/2001 | US6228576 Detecting enzymes inhibitor of a preferential polymerase; incubate sample and inhibitor, detect polymerase activity |
| 05/08/2001 | US6228372 Polypeptides with amino acid sequences and peptides |
| 05/08/2001 | US6228364 Isolation of polypeptides with sequences |
| 05/08/2001 | US6228363 Peptides for the treatment of systemic lupus erythematosus |
| 05/08/2001 | US6228362 Boron neutron capture therapy using pre-targeting methods |
| 05/08/2001 | US6228361 Antisticking agents to prevent bonding |
| 05/08/2001 | US6228360 Immunoglobulins binding to human von willebrand factor with chains |
| 05/08/2001 | CA2096010C Recombinant feline coronavirus s proteins |
| 05/08/2001 | CA2087003C Hrsv vaccine |
| 05/08/2001 | CA2066661C Viral vaccine conjugates |
| 05/04/2001 | CA2288530A1 Immunofluorescence compound for imaging of tumors |
| 05/03/2001 | WO2001031343A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 05/03/2001 | WO2001031065A1 Humanization of non-human, mammalian antibodies |
| 05/03/2001 | WO2001031029A2 Human sphingosine kinase gene |
| 05/03/2001 | WO2001031021A1 Multiple sclerosis-related superantigen |
| 05/03/2001 | WO2001031019A2 Neisserial antigenic peptides |
| 05/03/2001 | WO2001031016A2 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | WO2001031008A2 Human and rat fgf-20 genes and gene expression products |
| 05/03/2001 | WO2001031007A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | WO2001031006A2 Serum amyloid a isoform from colostrum |
| 05/03/2001 | WO2001031005A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | WO2001030987A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | WO2001030972A2 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | WO2001030969A2 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/03/2001 | WO2001030854A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 05/03/2001 | WO2001030853A1 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 05/03/2001 | WO2001030852A1 Production of immunoglobulins which binds heterologous fcr with modified affinity |
| 05/03/2001 | WO2001030851A2 Idiotype vaccines |
| 05/03/2001 | WO2001030848A2 Nucleic acids of the human abc1 gene and applications thereof |
| 05/03/2001 | WO2001030846A1 Beta-defensins |
| 05/03/2001 | WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | WO2001030815A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | WO2001030814A1 Deglycosylated env/cd4 complex and the use thereof for vaccination against hiv |
| 05/03/2001 | WO2001030393A2 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 05/03/2001 | WO2001030392A2 Delivery of proteins across polar epithelial cell layers |
| 05/03/2001 | WO2001030386A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 05/03/2001 | WO2001030381A2 Use of csf-1 inhibitors |
| 05/03/2001 | WO2001030378A1 A method of prophylaxis and treatment |
| 05/03/2001 | WO2001030377A1 Porcine b7-1 and antibodies thereto |
| 05/03/2001 | WO2001030369A1 Process for inducing immunological tolerance for xenogeneic transplants |
| 05/03/2001 | WO2001030360A1 Modulation of l-selectin shedding via inhibition of tumor necrosis factor alpha converting enzyme (tace) |
| 05/03/2001 | WO2001030300A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | WO2001030168A1 Method of obtaining immunoglobulins from colostrum and dairy sources |
| 05/03/2001 | WO2001012840A3 Anti-epha2 antibodies as a cancer diagnostic |
| 05/03/2001 | WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 05/03/2001 | WO2000078802A3 Secreted polypeptides and corresponding polynucleotides |
| 05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 05/03/2001 | WO2000072876A3 Prevention and treatment of amyloidogenic disease |
| 05/03/2001 | WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 05/03/2001 | WO2000056774A8 Methods of using bioelastomers |
| 05/03/2001 | DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389321A1 Neisserial antigenic peptides |
| 05/03/2001 | CA2389256A1 Beta-defensins |
| 05/03/2001 | CA2389127A1 Human sphingosine kinase gene |
| 05/03/2001 | CA2389110A1 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |
| 05/03/2001 | CA2388637A1 Human fgf-20 gene and gene expression products |
| 05/03/2001 | CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388332A1 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | CA2388298A1 The use of csf-1 inhibitors |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2387889A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 05/03/2001 | CA2387685A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/03/2001 | CA2387666A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | CA2387652A1 A method of prophylaxis and treatment |
| 05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | CA2386926A1 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 05/03/2001 | CA2361637A1 Porcine b7-1 and antibodies thereto |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095948A1 Idiotype vaccines |
| 05/02/2001 | EP1095417A1 Transition metal based ceramic material and electrodes fabricated therefrom |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |